Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
RFK Jr. releases new dietary guidelines with emphasis on protein, full-fat dairy - 2How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker
- 3The most effective method to Integrate Compact disc Rates into Your Retirement Arranging
- 4Famous Network programs in Europe and America
- 5Rights group: At least 2,500 deaths during protest crackdown in Iran
- The Conclusive Manual for Spending plan Travel: Opening Undertakings on a Tight budget
- Exploring Programming Greatness: A Survey of \Easy to use Connection points\
- Carina Nebula shines with white-blue stars | Space photo of the day for Jan. 5, 2026
- OECD: Iran war dampening global growth
- Instructions to Comprehend and Use Open Record Extra Offers
- The Most Astonishing Arising Advancements to Watch
- 'All's Fair,' Ryan Murphy's new show starring Kim Kardashian, hit with scathing reviews: 'A girlboss fever dream'
- What to expect from the planets in 2026 — key dates and sky events
- Astounding Treehouses All over the Planet
